Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Minerva Neurosciences, Inc - Common Stock
(NQ:
NERV
)
7.840
+0.150 (+1.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Minerva Neurosciences, Inc - Common Stock
< Previous
1
2
3
4
5
6
Next >
Top stock movements in today's session.
↗
March 09, 2026
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 28, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 22, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
October 22, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Minerva Neurosciences: Q4 Earnings Insights
↗
February 22, 2024
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
October 22, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst
↗
October 22, 2025
Shares surged 141% to $6.41, marking their highest level since February 2024, after Minerva secured up to $200 million in financing led by top healthcare investors.
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 21, 2025
Via
Benzinga
Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial
↗
October 21, 2025
Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding to support development of roluperidone for schizophrenia.
Via
Benzinga
These stocks are the most active in today's session
↗
October 21, 2025
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 21, 2025
Via
Benzinga
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
↗
October 21, 2025
Via
Benzinga
These stocks that are showing activity before the opening bell on Tuesday.
↗
October 21, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 21, 2025
Via
Benzinga
Unusual volume stocks are being observed in Wednesday's session.
↗
October 08, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Top movers in Wednesday's session
↗
October 08, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
April 14, 2025
Via
Benzinga
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
↗
August 06, 2024
NERV stock results show that Minerva Neurosciences missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
↗
May 01, 2024
NERV stock results show that Minerva Neurosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
↗
February 27, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41....
Via
Benzinga
Topics
Stocks
Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
↗
February 27, 2024
Minerva Neurosciences faces FDA challenges for roluperidone in schizophrenia treatment. Understand the clinical deficiencies and potential paths forward. Cash position at December 31, 2023, around...
Via
Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 27, 2024
Via
Benzinga
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
↗
February 27, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P...
Via
Benzinga
Topics
Stocks
Nasdaq Rises 50 Points; Lowe's Earnings Top Views
↗
February 27, 2024
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
February 05, 2024
Via
Benzinga
10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
↗
July 18, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Top 5 Health Care Stocks That May Collapse This Quarter
↗
July 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
